Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics cash
Cash and short-term investments held at the end of each period.
Bionano Genomics's cash was $9.92M at Jun 30, 2026. For fiscal 2025 it was $19.27M, up 103.4% from the year before. The highest annual figure on record is $250.61M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.27M | +103.4% |
| FY2024 | Dec 31, 2024 | $9.48M | -85.8% |
| FY2023 | Dec 31, 2023 | $66.77M | -41.0% |
| FY2022 | Dec 31, 2022 | $113.19M | -54.8% |
| FY2021 | Dec 31, 2021 | $250.61M | +551.8% |
| FY2020 | Dec 31, 2020 | $38.45M | +122.1% |
| FY2019 | Dec 31, 2019 | $17.31M | +4.8% |
| FY2018 | Dec 31, 2018 | $16.52M | +1516.9% |
| FY2017 | Dec 31, 2017 | $1.02M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.92M | -39.7% |
| Q1 FY2026 | Mar 31, 2026 | $14.41M | -21.0% |
| Q4 FY2025 | Dec 31, 2025 | $19.27M | +103.4% |
| Q3 FY2025 | Sep 30, 2025 | $21.58M | +80.5% |
| Q2 FY2025 | Jun 30, 2025 | $16.44M | -13.2% |
| Q1 FY2025 | Mar 31, 2025 | $18.23M | -35.6% |
| Q4 FY2024 | Dec 31, 2024 | $9.48M | -85.8% |
| Q3 FY2024 | Sep 30, 2024 | $11.95M | -81.2% |
| Q2 FY2024 | Jun 30, 2024 | $18.94M | -75.4% |
| Q1 FY2024 | Mar 31, 2024 | $28.32M | -70.4% |
| Q4 FY2023 | Dec 31, 2023 | $66.77M | -41.0% |
| Q3 FY2023 | Sep 30, 2023 | $63.58M | -64.7% |
| Q2 FY2023 | Jun 30, 2023 | $77.06M | -58.9% |
| Q1 FY2023 | Mar 31, 2023 | $95.81M | -55.7% |
| Q4 FY2022 | Dec 31, 2022 | $113.19M | -54.8% |
| Q3 FY2022 | Sep 30, 2022 | $180.19M | -44.7% |
| Q2 FY2022 | Jun 30, 2022 | $187.34M | -43.7% |
| Q1 FY2022 | Mar 31, 2022 | $216.47M | -40.2% |
| Q4 FY2021 | Dec 31, 2021 | $250.61M | +551.8% |
| Q3 FY2021 | Sep 30, 2021 | $326.07M | +1628.3% |
| Q2 FY2021 | Jun 30, 2021 | $332.55M | +1834.1% |
| Q1 FY2021 | Mar 31, 2021 | $362.06M | +4345.7% |
| Q4 FY2020 | Dec 31, 2020 | $38.45M | +122.1% |
| Q3 FY2020 | Sep 30, 2020 | $18.87M | +129.4% |
| Q2 FY2020 | Jun 30, 2020 | $17.19M | +12.4% |
| Q1 FY2020 | Mar 31, 2020 | $8.14M | -60.9% |
| Q4 FY2019 | Dec 31, 2019 | $17.31M | +4.8% |
| Q3 FY2019 | Sep 30, 2019 | $8.23M | -60.2% |
| Q2 FY2019 | Jun 30, 2019 | $15.30M | +1396.7% |
| Q1 FY2019 | Mar 31, 2019 | $20.83M | – |
| Q4 FY2018 | Dec 31, 2018 | $16.52M | – |
| Q3 FY2018 | Sep 30, 2018 | $20.66M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.02M | – |
See a number that looks wrong?